Dar Al Dawa Development and Investment (AMM:DADI) LT-Debt-to-Total-Asset : 0.00 (As of Dec. 2024)

View and export this data going back to 1978. Start your Free Trial

What is Dar Al Dawa Development and Investment LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Dar Al Dawa Development and Investment's long-term debt to total assests ratio for the quarter that ended in Dec. 2024 was 0.00.

Dar Al Dawa Development and Investment's long-term debt to total assets ratio stayed the same from Dec. 2023 (0.00) to Dec. 2024 (0.00).

Dar Al Dawa Development and Investment LT-Debt-to-Total-Asset Historical Data

The historical data trend for Dar Al Dawa Development and Investment's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dar Al Dawa Development and Investment LT-Debt-to-Total-Asset Chart

Dar Al Dawa Development and Investment Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.09

0.04

0.03

Dar Al Dawa Development and Investment Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															-	-	-	-	-

Dar Al Dawa Development and Investment LT-Debt-to-Total-Asset Calculation

Dar Al Dawa Development and Investment's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (A: Dec. 2024 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2024 )	/	Total Assets (A: Dec. 2024 )
	=	0.285	/	124.161
	=	0.00

Dar Al Dawa Development and Investment's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (Q: Dec. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2024 )	/	Total Assets (Q: Dec. 2024 )
	=	0.285	/	124.161
	=	0.00

Dar Al Dawa Development and Investment (AMM:DADI) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Dar Al Dawa Development and Investment LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Dar Al Dawa Development and Investment's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Dar Al Dawa Development and Investment Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dar Al Dawa Development and Investment (AMM:DADI) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

Naour, P.O. Box 9364, Amman, JOR, 11191

Website

https://www.dadgroup.com

Dar Al Dawa Development and Investment is a pharmaceutical company. The main objectives of the company are to manufacture pharmaceutical, chemical, pharmaceutical, and related products and to import medicines. It offers products in the therapeutic areas of anti-infective, cardiovascular and diabetes, dermatology, eye-ear preparations, gastroenterology and metabolism, genitourinary system and sex hormones, musculoskeletal system, nervous system, ophthalmological/otological, and respiratory system, as well as vitamins. The company's geographical segments are Levant and Iraq, Gulf and Yemen, Africa, and Europe and Asia.

Dar Al Dawa Development and Investment Headlines

No Headlines